Venous Thromboembolism Therapeutics
List the two types of Venous Thromboembolisms (VTE)
- Deep Venous Thrombosis
- Pulmonary Embolism
What is a VTE?
Fibrin clot formation w/in the venous system
List factors that could contribute to a VTE
- Venous stasis
- Vessel wall injury
- Hypercoagulability
Which kind of thrombosis is a formation of a clot in a deep vein of the body/
DVT
Veins located where are the most commonly affected by DVT
Legs
What are the most common veins w/in the leg that are affected by DVT?
Proximal (femoral, popliteal, and iliac veins)
Which distal veins in the leg can be affected by DVT?
Calf veins
Blockage of a main artery of the lung or one of its branches is known as _______
Pulmonary Embolism (PE)
PE most commonly results from __________ that breaks off and migrates to the lungs
DVT
What is a common symptoms of a PE?
SOB
T/F: Incidence of VTE triples each decade over 45
False
Describe the pathophysiology of a VTE
- Vascular injury --> hemostatic plug forms and seals wall --> prevent further blood loss
- Disruption of system =
inappropriate clot formation
- Obstructs BF
- Embolizes to distant vascular bed
What are the parts of Virchow's Triad?
- Venous stasis
- Vessel wall injury
- Hypercoagulability
Risk factors of VTE
- Age (>50)
- History of VTE
- Hypercoagulable states
- Venous stasis
- Vascular injury
- Medications
List examples of hypercoagulable states:
- Pregnancy
- Malignancy
- Activated ptn C resistance factor/factor V Leiden
- Prothrombin (G20210A) gene mutation
- Ptn C or S deficiency
- Anti-thrombin deficiency
- Anti-phospholipid antibodies
List examples of venous stasis that could increase risk of blood clot
- Acute medical illness
- Surgery
- Paralysis
- Immobility
- Obesity
List examples of vascular injury that could increase risk of blood clot
- Major orthopedic surgery
- Trauma
- Central venous catheter
List examples of medication that could increase risk of blood clot
- Oral contraceptive
- Estrogen replacement therapy
- Selective estrogen receptor modulators (SERMs)
- Chemotherapy
- Heparin (HIT)
T/F: Most DVT pts have no symptoms. If they do have symptoms, typically the s/sx are bilateral and non-specific.
False
List symptoms of DVT
- Leg pain
- Swelling
- Warmth
- Redness
List the signs of DVT
- Dilated superficial veins
- Palpable cord
- Homan's sign
- Low-grade fever
T/F: When assessing for a DVT, we use the symptoms more than signs (signs are not super specific and we don't usually look for those)
True
T/F: D-dimer is a diagnostic blood test used to evaluate for VTE. It is a screening tool only (not used for diagnosis)
True
D-dimer <500ng/mL =
rule out VTE
D-dimer >500 ng/mL =
Possible VTE
D-dimer has high ___________(sensitivity/specificity) and low ___________(sensitivity/specificity)
Sensitivity; specificity
T/F: D-dimer levels are decreased in acute thrombosis
False
__________ is a degradation product of a fibrin clot used as a screening tool for VTE
D-dimer
T/F: A higher score on the Well's criteria for DVT = higher risk for DVT
True
What is the most common way to diagnose a DVT?
Duplex Ultrasonography ("dopplers")
What does Duplex Ultrasonography ("dopplers") do in regards to DVT?
- Measures rate and direction of BF
- Visualizes clot in proximal veins of legs
What is the gold standard (but last line) way to diagnose DVT?
Venography
Why is venography last line for DVT diagnosis?
- Invasive and expensive
- Pt anesthetized and dye injected (anaphylactic risk) to show where clot is
List the complications of DVT
- PE
- Post-thrombotic syndrome
Describe post-thrombotic syndrome
- Long term complication of DVT
- Damage to venous valves after DVT is treated
Symptoms of post-thrombotic syndrome:
- Chronic lower extremity edema
- Pain
- Tenderness
- Skin discoloration
- Ulceration
T/F: Many pts w/ PE may present w/ symptomatic DVT
True
S/Sx of PE depend on what?
Massive vs. submassive PE
Symptoms of PE:
- Cough
- CP, chest tightness, palpitations
- SOB
- Hemoptysis
- Dizziness, lightheadedness, syncope
Signs of PE
- Tachypnea
- Tachycardia
- Diaphoresis
- Cyanosis, hypoxia
- Hypotension
- Circulatory shock
- Low-grade fever
What is the most common tool for diagnosing PE?
Computerized Tomography (CT)
How does a CT work?
- IV injection of iodine-contrast agent (dye)
- Contrast filling defects occur when emboli is present w/in pulmonary arteries
T/F: CT iodine-contrast agent is less likely to cause anaphylaxis by dye (compared to venography)
True
What is the second line diagnosis tool for PE?
Ventilation/Perfusion (VQ)
How does Ventilation/Perfusion (VQ) work?
- Measures distribution of blood and air flow in the lungs
- Large mismatch = high probability of PE
What is the third line diagnosis tool for PE?
Duplex Ultrasonography ("dopplers") of lower extremities
What is the gold standard (but last line) diagnostic tool for PE?
Pulmonary angiography
Why is Pulmonary angiography last line for PE diagnosis?
- Invasive and expensive
- Anaphylactic risk ~15%
T/F: Diagnosis of PE is associated w/ significant morbidity and mortality
True
T/F: Sudden death is the first symptom in ~25% of pts who have a PE
True
Goals of therapy for DVT:
- Prevent thrombus embolization/extension
- Prevent recurrence
- Prevent post-thrombotic syndrome
Goals of therapy for PE
- Prevent recurrence
- Decrease mortality
Orthopedic pts need to b on what additional therapy?
Blood thinner and anti-coagulant
List the initial VTE therapy options:
- Warfarin (+LMWH / UFH / Fondaparinux for first 5d)
- Rivaroxaban, Apixaban, Edoxaban, Dabigatron
- LMWH or Fondaparinux (select pts only)
How long should warfarin therapy overlap w/ either LMWH/UFH/Fondaparinux?
Minimum 5d until INR is >2.0 for at least 24 hrs (2 consecutive readings)
Which pts can use the injectable products LMWH or Fondaparinux?
- Cancer pts
- Pregnant pts
Why must therapy with warfarin and a parenteral anticoagulant be overlapped?
Hypercoagulable state develops in first 24 hrs bc ptn C has a short t1/2 and warfarin inhibits it = leaves body fastest. W/o this natural anticoagulant = increased risk of clot until therapeutic warfarin level reached.
Duration of therapy for first provoked VTE
3 mo
Duration of therapy for idiopathic VTE
3 mo, re-evaluate for extended therapy
Duration of therapy for 2 or more VTE
Indefinite
Duration of therapy for VTE w/ active cancer
Indefinite (as long as cancer is present)
Duration of therapy for:
- Anti-phospholipid antibodies
- Factor V leiden
- Prothrombin mutation
Indefinite
Non-pharm therapy for VTE
- Ambulation
- Mechanical
- Graduated compression stockings (GCS)
- Intermittent pneumatic compression devices (IPC)
- inferior vena cava (IVC) filters
Indications for UFH therapy
- VTE prophylaxis
- Trtmt of VTE (hospital setting)
MOA of UFH:
- Enhances anti-thrombin
- Inhibits platelet aggregation
- Prevents growth and propagation of a formed thrombosis
Administration of UFH
- SQ (VTE prophylaxis)
- IV (VTE trtmt)
UFH t1/2 :
30-90 min
UFH elimination
Enzymatically inactivated by heparinases and desulfatases
T/F: Prophylaxis UFH should be monitored w/ aPTT
False
LD of IV UFH for VTE treatment:
80 u/kg
Max LD of IV UFH
10,000 u
Initial maintenance dose of IV UFH for VTE treatment:
18 u/kg/hr
Subsequent maintenance dose of IV UFH for VTE treatment
Adjusted based on lab monitoring to achieve therapeutic anti-coagulation
Goal aPTT for IV UFH for VTE treatment
1.5-2.5 * control
Goal anti-factor Xa for IV UFH for VTE treatment
0.3-0.7 u/mL
Lab monitoring for IV UFH for VTE treatment
- aPTT
Anti-factor Xa
Which monitoring test for UFH is sensitive to changes in the intrinsic and common coagulation pathways?
aPTT
How is the aPTT test performed?
Measuring time required for clot formation after the addition of phospholipid, an activator (silica, celite, kaolin, ellagic acid), and Ca to citrated plasma
T/F: aPTT can vary based on the reagent used to test the sample
True
When would aPTT be measured?
- Baseline
- 6 hrs after UFH initiation
- 6 hrs after UFH dose change
- Q24hrs when stable
AE of UFH
- Major Bleeding
- GI
- soft tissues
- Urinary tract
- Minor bleeding
- Epistaxis
- Gingival bleeding
- Prolonged bleeding from cuts
- Bruising
UFH monitoring:
- aPTT/antifactor Xa levels
- Hgb/Hct
- Platelets
UFH antidote:
IV protamine sulfate
Additional UFH AEs
- Injxn site rxns
- HIT
- LT effects (priapism, alopecia, osteoporosis, suppressed aldosterone synthesis)
SQ UFH monitoring:
none
T/F: Renal dose adjustment is required for renal insufficiency
False
UFH pregnancy category
C
T/F: We cannot use UFH in pregnant pts, but we can use it in children
False
Hepatic insufficiency means there will be enhanced anticogulant effects. Do we need hepatic dose adjustment for UFH?
No
Which LMWH is most commonly used for prophylaxis, VTE treatment, and VTE treatment in cancer and pregnant patients?
Enoxaparin (Lovenox)
MOA of LMWH
- Enhances effects of anti-thrombin
- Prevents growth and propagation of a formed thrombus
Elimination of LMWHs:
Renal (requires renal dose adjustment)
Which LMWHs are used as prevention of VTE in cases of acute medical illness?
Enoxaparin and Dalteparin
Monitoring for LMWH in prevention (acute medical illness)
none
Normal dose and freq of enoxaparin
1 mg/kg SQ q12h
Dose and freq for enoxaparin if CrCl <30 mL/min
1 mg/kg SQ q24h
What will always need to be monitored with LMWH?
CBC
How often should CBC be measured with LMWH?
- Baseline
- q5-10 days for first 2 wks
- q2-4 weeks for duration of therapy
Under what circumstances should anti-Xa levels be measured for a pt on LMWH?
- CrCl <30 mL/min
- BW <50 kg or >100 kg
- Prolonged therapy
- Pregnant females
- pediatric pts
- high risk for bleeding
Anti-Xa goal level:
0.6-1.0 u/mL
If a pt who is on LMWH is determined to need anti-Xa monitoring, when would you need to monitor?
4 hrs after 3rd dose
Antidote for LMWH
IV protamine
BBW for LMWH
Spinal hematoma that could lead to paralysis if given w/ epidural
Major and minor AE for LMWH
- Major: bleeding (less so than heparin)
- Minor: injxn site rxn
T/F: If pt previously experienced HIT, you can not use LMWH.
True
T/F: There is less incidence of HIT/long term effects with LMWH compared to UFH
True
T/F: LMWH is safe to use in pregnant pts, but not pediatrics
False
If a pt has severe rheumatoid arthritis in their hands, would LMWH be a good recommendation for them?
No, they will struggle to give themselves the injection
Advantages of LMWH over UFH
- Predictable anticoagulation dose response
- Improved SQ bioavailability
- Dose-dependent clearance
- Longer half-life
- Lower incidence of HIT
Reduced monitoring need - Outpt management of VTE
Fondaparinux brand
Arixtra
Rivaroxaban brand
Xarelto
Apixaban brand
Eliquis
Edoxaban brand
Savaysa
Betrixaban brand
Bevyxxa
List the factor Xa inhibitors
- Fondaparinux
- Rivaroxaban
- Apixaban
- Edoxaban
- Betrixaban
Which factor Xa inhibitors are first line?
Oral ones
T/F: Fondaparinux is used for the treatment and prevention of VTE and is weight based dosing
True
Antidote for fondaparinux
none
T/F: Fondaparinux cannot be used for management of HIT
False
Fondaparinux is contraindicated in:
CrCl <30 mL/min
Describe the dosing for Rivaroxaban in the treatment of VTE (initial and after initial treatment)
- Initial: 15 mg PO BID with food x21d
- After: 20 mg PO daily with food
Rivaroxaban monitoring
CBC (baseline then periodically)
Why must rivaroxaban be taken with food?
Bioavailability drops to 0 without food (~200 calories)
Rivaroxaban/apixaban antidote
Andexxa
Rivaroxaban is contraindicated in:
CrCl <30 mL/min
Rivaroxaban/apixaban drug interactions
Cyp3A4 inhibitors/inducers
Describe the dosing for Apixaban in the treatment of VTE (initial and after initial treatment)
- Initial: 10 mg PO BID with food x7 days
- After: 5 mg PO BID
T/F: Rivaroxaban and Apixaban are contraindicated in pts with CrCl <30 mL/min
False
Describe treatment of VTE with Edoxaban
- Initial: At least 5-10 d of pernteral anticoagulant
- THEN start edoxaban (i.e. on day 6)
Antidote for edoxaban
none
Betrixaban is used for:
Prevention of VTE
Direct thrombin inhibitors are used primarily for:
HIT
Dabigatran brand
Pradaxa
Dabigatran MOA
Selectively inhibits factor IIa (thrombin)
T/F: If a patient is starting dabigatran, they would need to be on a parenteral anticoagulant for 5-10d, THEN can start dabigatran on day 6
True
Unique AE of pradaxa
dyspepsia
Antidote of Dabigatran
Idarucizumab (Praxbind)
Warfarin brand
Coumadin
T/F: Rivaroxaban, Apixaban, dabigatron, and warfarin are all first line
False
Warfarin dosing:
- 5-10 mg PO daily
- 2.5 mg PO daily: >65 yo, malnourished, liver dz, heart failure, concurrent use of interacting meds
Warfarin is metabolized by:
CYP 1A2, 2C19, 3A4, and 2C9
Warfarin dose changes should not be made more frequently than:
q3d
Goal for INR for warfarin
2-3
INR <2 means
Increased risk for blood clot
INR >3 means
Increased risk for bleeding
How often is INR monitored?
- Baseline
- q3d during first week
- q7-14d until stabilized
- q4wks thereafter
- Can extend to q 12 weeks in pts w/ consistent/stable INR
Why should you give a pt one strength of warfarin (even if the dose varies throughout the week)?
Minimize chance for pt to make an error in which dose they're taking. (i.e. so they don't accidentally take a much higher/lower dose than they were supposed to)
AE of warfarin
- Bleeding
- purple toe syndrome
- Warfarin-induced skin necrosis (very rare)
Management of supratherapeutic warfarin: INR above therapeutic range but < 4.5; no significant bleeding
Reduce/skip warfarin dose, monitor INR. Resume warfarin when therapeutic
Management of supratherapeutic warfarin: INR bw 4.5-10; no significant bleeding
Hold 1-2 doses of warfarin. Monitor INR. Resume at lower dose when INR is therapeutic
Management of supratherapeutic warfarin: INR >10; no significant bleeding
Hold warfarin and give oral vitamin K. Monitor INR and resume when therapeutic
Management of supratherapeutic warfarin with major bleed
Hold warfarin. admin prothrombin complex concentrate and vitamin K by slow IV infusion
If a pt is having a scheduled surgery, warfarin should be stopped for _____ d before the surgery, and resumed ~_______ after surgery?
5d; 12-24 hrs
T/F: If a pt is having a scheduled surgery and stops their warfarin, they do not need a bridge therapy since it is only a temporary pause in the warfarin
False
Warfarin pregnancy category
X
T/F: Warfarin can be used in peds, pts with renal insufficiency, and pts with hepatic insufficiency
True
Examples of drugs warfarin interacts with
- NSAIDS (increase bleed risk)
- Aspirin (increase bleed risk)
- Amiodarone (increases warfarin levels)
Warfarin important pt counseling:
- Take every day
- Maintain consistent vitamin K intake
- Attend follow-up for INR
- No alcohol (or NMT 1 12oz beer/d)
Anticoagulants to use in pregancy:
- UFH
- LMWH
Anticoagulants to use in peds
- UFH/LMWH
- Warfarin
Anticoagulants to use in cancer pts
LMWH